Their potential as biomarkers was investigated analyzing serum samples of patients with mild and severe NAFLD; through microarray analysis several ncRNAs were identified, and specifically the expression of TGFB2/TGFB2‐OT1 allowed advanced fibrosis discrimination.260. Here, TGFB2 is linked to metabolic dysfunction-associated steatotic liver disease.